PIK3CA and breast carcinoma: Another study reported PIK3CA somatic mutations in hepatocellular carcinomas (35.6%), breast carcinomas (26.9%), gastric carcinomas (6.5%), acute leukemias (1.1%) and non-small-cell lung cancers (1.3%) [394].